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INFECTIOUS DISE ASE 
Implementing Pasteur’s vision  
for rabies elimination 
Human and veterinary health systems must be better integrated. 
By Felix Lankester,1,2,3* Katie Hampson,3 Tiziana Lembo,3 Guy Palmer,1,2 Louise Taylor,4 and Sarah Cleaveland2,3 
It has been 129 years since Louis Pasteur’s 
experimental protocol saved the life of a 
child mauled by a rabid dog, despite incom-
plete understanding of the etiology or 
mechanisms by which the miracle cure 
worked (1). The disease has since been well 
understood, and highly effective vaccines are available, yet Pasteur’s vision for ridding 
the world of rabies has not been realized. Rabies remains a threat to half the world’s 
population and kills more than 69,000 peo-
ple each year, most of them children (2). We 
discuss the basis for this neglect and present 
evidence supporting the feasibility of elimi-
nating canine-mediated rabies and the re-
quired policy actions.  
A NEGLECTED PRIORITY. Because of effec-
tive control of rabies in domestic dogs, it is 
no longer a disease of major concern in de-
veloped countries. In 2013, the one person 
diagnosed with rabies in the United States, 
which was predictably fatal, acquired the in-
fection in Guatemala. In Western Europe no 
cases were reported in 2013; the one per-
son who died of canine-mediated rabies in 
2012 was bitten by a dog in India. With 
more than 95% of human cases occurring in 
Africa and Asia (3), largely in rural and im-
poverished communities, rabies threatens 
the world’s most marginalized people. Even 
in low-income countries, those from more 
affluent areas rarely die of rabies, as they 
are likely to promptly access highly effective 
postexposure prophylaxis (PEP). It is the 
poor who die; they are more frequently vic-
tims of rabid dog attacks, they suffer fatal 
delays in trying to access PEP, or simply 
cannot afford to pay for it (4).  
Despite recent developments of simple, 
rapid, and highly accurate diagnostic meth-
ods (5), underdiagnosis and underreporting 
contribute to rabies neglect. The true inci-
dence of human rabies in Asia and Africa is 
estimated to be between 20 and 160 times 
what is officially reported (3). The reasons 
for this are common among neglected dis-
eases in low-income countries: The afflicted 
often do not reach medical facilities (4) so 
are never recorded. For those who attend a 
medical facility, the similarity of rabies 
symptoms to other neurologic conditions, 
including cerebral malaria (6), renders clini-
cal diagnosis without laboratory support 
challenging. Even where laboratory facilities 
exist, diagnostic samples are rarely collect-
ed, and where a clinical diagnosis is made, 
many cases are not reported to national or 
international authorities.  
Coupled with this structural 
underdiagnosis and underreporting is the 
current approach to prioritizing disease in-
terventions. Predominant disease burden 
metrics, such as disability-adjusted live 
years (DALYs), are important in focusing re-
search and intervention agendas. However, 
decisions should also take into account the 
availability and effectiveness of control in-
terventions and their implementation cost. 
For rabies, although a DALY score of 1.74 
million lost per year is low compared with 
HIV, malaria, or tuberculosis, highly effective 
animal vaccines are available to control and 
eliminate disease in animal reservoirs and 
to prevent human deaths for a price consid-
ered highly cost-effective (7–9). 
Although global concerns relating to avi-
an influenza have helped bridge medical and 
veterinary disciplines, a responsibility gap 
remains for zoonotic diseases not consid-
ered a global threat. For rabies, prevention 
through dog vaccination is the province of 
veterinary medicine, whereas PEP is the re-
sponsibility of physicians and nurses. Budg-
ets to address rabies are rarely considered 
jointly, which results in ever-increasing PEP 
costs if the disease is not tackled at the ani-
mal source. As rabies does not cause a high 
burden of disease in livestock, compared 
with many economically important 
transboundary livestock diseases, dog vac-
cination has not been prioritized by veteri-
nary services in low-income countries. 
However, if viewed more broadly as a socie-
tal burden, rather than by using a single 
health or economic metric, the impact of ra-
bies and priority for its control is substan-
tially elevated (2, 8).  
A One Health approach, integrating med-
ical and veterinary sectors, is important 
both to develop appropriate metrics for 
evaluating the disease burden, and to en-
sure shared operational responsibility for zoonosis control and prevention. Although 
international funding can facilitate this co-
ordination (as shown for avian influenza), 
the most critical requirements are political 
commitment and building of trust and effec-
tive communication between sectors, which 
need not be prohibitively costly. Establish-
ment of an effective interministerial Zoono-
tic Disease Unit in Kenya, which has rapidly 
developed integrated national plans for ra-
bies control and elimination, provides a re-
cent example of One Health coordination in-
volving not only health and veterinary 
sectors but also wildlife services concerned 
with the threat that rabies poses to endan-
gered wildlife.   
ELIMINATION IS ACHIEVABLE. Although 
rabies virus is a multihost pathogen, the 
domestic dog remains the principal reser-
voir and source of human rabies. The basic 
reproductive number for rabies (R0, the av-erage number of new cases generated by a 
single case) is consistently low (R0 < 2) in 
dog populations worldwide, despite wide 
variations in population density (10). This 
suggests that transmission can be relatively 
easily interrupted through mass dog vac-
cination but not through the reduction of 
dog density, an approach that, despite being 
the first response to many rabies outbreaks 
(11), has never been successful (12). A growing body of evidence from Central 
and South America and pilot projects in 
Southeast Asia and Africa demonstrate the 
effectiveness of dog vaccination as a means 
to prevent human rabies in both high- and 
low-income countries (13). Annual vaccina-
tion coverage of 70% controls and eventual-
ly eliminates the disease (Fig. 1) (10).  
Despite misperceptions of large “stray” 
dog populations, a high proportion of dogs are accessible for highly efficacious paren-
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teral vaccination campaigns (14). Less than 11% of the dog population has been identi-
fied as ownerless in Zimbabwe, Chad, Tan-zania, and South Africa (15). In densely 
populated Asian settings, where community 
dogs are common, techniques for vaccinat-ing free-roaming dogs have been successful-
ly applied (11).  
Studies of rabies epidemiology in the 
Serengeti National Park in Tanzania and the 
surrounding communities demonstrate that 
domestic dogs, not wildlife, drive rabies 
transmission dynamics (16). Where dog ra-
bies has been locally eliminated, the disease 
disappears in all species (15). This gener-
ates confidence that control of canine rabies is epidemiologically achievable and that 
large-scale elimination is a realistic goal. This has been demonstrated by the reduc-
tion in canine rabies by around 99% across 
Latin America, with elimination targets for 
the region set for 2015 (17). 
Is elimination of canine rabies economi-
cally feasible? Empirical and theoretical 
studies of mass dog vaccination campaigns 
in low-income countries reveal that vac-
cinating dogs against rabies is cost-effective 
up to the critical 70% vaccination coverage 
threshold (Fig. 1) (9), is significantly less expensive over the long-term than provid-ing PEP to bite victims, and can result in 
substantial savings to the public health sec-
tor (8, 9, 18). These savings will be particu-
larly relevant in Asia where currently 90% 
of global PEP is administered (2, 3). To real-
ize these savings, initial external financing 
may be needed to support investments in 
dog vaccination. However, to ensure sus-
tainability, financing strategies need to in-
volve governments and to have flexibility to 
encourage community engagement and to 
exploit new approaches to enhance cost-
effectiveness, such as linking dog vaccina-
tion with other health delivery platforms.  
 
ACROSS DISCIPLINES AND BORDERS. The 
only infectious diseases deliberately eradi-
cated worldwide, smallpox and rinderpest, 
were within exclusive domains of human 
and veterinary medicine, respectively. Elim-
inating canine rabies as a public health bur-
den will require a One Health approach in-
tegrated across sectors. This has proven 
much easier to advocate in theory than to 
achieve in practice. Many low-income coun-
tries face a considerable challenge in coor-
dinating and integrating activities across 
decentralized and fragmented veterinary 
and health care systems. This is exacerbated 
by a lack of linked regulatory policies.  
Although growing scientific evidence is 
addressing misperceptions about canine ra-
bies epidemiology and control, progress in 
many countries is still hampered by lack of 
political commitment and financing mecha-
nisms. Pilot projects in Africa and Asia, 
which have supported initial investments in 
dog rabies control, demonstrate the power 
of catalytic funding to achieve operational 
progress, and allow veterinary and health services to move away from short-term or 
emergency responses toward a more coor-
dinated and proactive program of disease 
prevention and control. Work is needed to 
determine how best to scale up from such 
pilot studies to the national and regional 
programs that will be needed for eventual 
elimination. International human and ani-
mal health organizations can play an im-
portant support role, for example, establish-
ing mechanisms to ensure the affordable 
supply of human and animal vaccines and 
their effective cross-sectoral use.  
An enduring challenge for global elimi-
nation is the ability to work effectively 
across national boundaries. This has been 
achieved successfully in the 
Americas through the 
REDIPRA network (Directors 
of National Rabies Control 
Programs), with specific budg-
ets for cross-border control 
and the transparent sharing of 
surveillance and budgetary in-
formation resulting in a collec-
tive commitment to a public 
good, as well as constructive 
peer pressure. Newer regional 
rabies networks in Asia and Africa could develop along the 
same lines. Successful rabies 
control programs in KwaZulu-
Natal, South Africa, supported 
through pilot funding, have re-
sulted in transboundary networks and initi-
atives in neighboring countries. Initial suc-
cess provides momentum for further suc-cess. 
Canine rabies elimination meets all the 
criteria for a global health priority: It is epi-
demiologically and logistically feasible, cost-
effective, and socially equitable. Pasteur’s vi-sion is within our reach—we only need to 
move the hand forward to grasp it. 
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Fig. 1. Impact of dog vaccination coverage 
on rabies outbreak probability and cost. 
The left-hand axis and the dashed blue line 
show the probability of an outbreak of 10 or 
more cases being seeded by an introduced 
case under different levels of vaccination 
coverage. The right-hand axis and solid red 
line indicate the total costs per km2 (U.S.$) of 
rabies control with increasing vaccination 
coverage. Vaccination coverage of 70% of 
the canine population reduces outbreak prob-
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ability close to zero and is cost-effective. Cost 
data from (9), probability data from (10).  
 
 
 
